Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Cryo Cell International (CCEL) over the last 16 years, with Q3 2025 value amounting to $2.5 million.

  • Cryo Cell International's Cash from Operations rose 407.89% to $2.5 million in Q3 2025 from the same period last year, while for Aug 2025 it was $6.4 million, marking a year-over-year decrease of 1171.74%. This contributed to the annual value of $6.0 million for FY2024, which is 3261.13% down from last year.
  • Per Cryo Cell International's latest filing, its Cash from Operations stood at $2.5 million for Q3 2025, which was up 407.89% from $707014.0 recorded in Q2 2025.
  • Over the past 5 years, Cryo Cell International's Cash from Operations peaked at $3.3 million during Q4 2023, and registered a low of -$356865.0 during Q1 2024.
  • Its 5-year average for Cash from Operations is $1.9 million, with a median of $1.9 million in 2022.
  • Per our database at Business Quant, Cryo Cell International's Cash from Operations tumbled by 12170.81% in 2024 and then skyrocketed by 36734.56% in 2025.
  • Quarter analysis of 5 years shows Cryo Cell International's Cash from Operations stood at $1.7 million in 2021, then soared by 45.71% to $2.4 million in 2022, then surged by 37.64% to $3.3 million in 2023, then plummeted by 35.5% to $2.2 million in 2024, then rose by 17.6% to $2.5 million in 2025.
  • Its last three reported values are $2.5 million in Q3 2025, $707014.0 for Q2 2025, and $954063.0 during Q1 2025.